Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A multicenter, randomized, double-blind, placebo-controlled Phase 3 study of JLP-2002 in overactive bladder
KCT0005651Phase 3Recruiting
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in overactive bladder (OAB) comparing JLP-2002 with Placebo (2 arms). Started Sep 2020; status: recruiting.
02
Drugs
vibegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on KCT0005651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005651.